Recently, a large number of studies have shown that the addition of proton 1H-spectroscopic imaging (1H-MRSI) and dynamic contrast enhanced imaging (DCEMR) to magnetic resonance (MR) could represent a powerful tool for the management of prostate cancer (CaP) in most of its aspects. This combination of MR techniques can substantially sustain the clinical management of patients with CaP at different levels: in particular, (1) in the initial assessment, reducing the need for more extensive biopsies and directing targeted biopsies; (2) in the definition of a biochemical progression after primary therapies, distinguishing between fibrotic reaction and local recurrence from CaP. (C) 2011 Elsevier Inc. All rights reserved.
Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer / Sciarra, A; Panebianco, V; Salciccia, S; Cattarino, S; Lisi, D; Gentilucci, A; Alfarone, A; Mariotti, G; Passariello, R.; Gentile, V. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 29:1(2011), pp. 12-20. [10.1016/j.urolonc.2009.06.001]
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Titolo: | Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer | |
Autori: | ||
Data di pubblicazione: | 2011 | |
Rivista: | ||
Citazione: | Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer / Sciarra, A; Panebianco, V; Salciccia, S; Cattarino, S; Lisi, D; Gentilucci, A; Alfarone, A; Mariotti, G; Passariello, R.; Gentile, V. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 29:1(2011), pp. 12-20. [10.1016/j.urolonc.2009.06.001] | |
Handle: | http://hdl.handle.net/11573/27910 | |
Appartiene alla tipologia: | 01a Articolo in rivista |